Cancer Treatment Certified Physician Examination Preparation | 50 Original Practice Questions Covering Frequently Tested Areas (with Answers and Explanations)The Cancer Treatment Certified Physician ...
If these drugs are designed to target cancer, why don't they work?Treatments that harness the power of the immune system to ...
Indie favorite Phoebe Bridgers opened her Lost Tour at Gainbridge Fieldhouse Sept. 14, launching a run of arena shows where ...
A platinum-relapsed SCLC patient achieved 16.7 months progression-free survival following Olvi-Vec and platinum rechallenge, exceeding the PFS achieved following platinum-based first-line therapy -- - ...
Obsidian Therapeutics is rated Hold due to overvaluation despite promising cell therapy technology targeting solid tumors.
Positive high-level results from a planned interim analysis of the DeLLphi-305 Phase III trial showed Imfinzi (durvalumab) plus Amgen's Imdelltra® ...
Bank of America Global Healthcare Conference 2026 September 22, 2026 5:05 AM EDTCompany ParticipantsMichael Quigley - Chief ...
Amgen (NASDAQ: AMGN) today announced landmark results from the Phase 3 DeLLphi-305 study, which met its primary endpoint at a pre-specified interim analysis, demonstrating a statistically significant ...
The announcement from Merck & Co. and Moderna last month that their mRNA cancer vaccine had successfully lengthened patient ...
First, a negative DAT does not exclude immune-mediated hemolysis, particularly in ICI-treated patients."BUFFALO, NY — September 10, 2026 — A new case ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results